HEADER HORMONE/GROWTH FACTOR 16-APR-04 1T1Q TITLE NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO- TITLE 2 B28-LYS, LYS-B29-PRO, 15 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: INSULIN A CHAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INSULIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: INSULIN B CHAIN; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS(HUMAN); SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 8 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS(HUMAN) KEYWDS ABA-B12-DKP-INSULIN, PROTEIN UNFOLDING, INSULIN RECEPTOR, RECEPTOR KEYWDS 2 BINDING, HORMONE-GROWTH FACTOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR K.HUANG,B.XU,S.Q.HU,Y.C.CHU,Q.X.HUA,J.WHITTAKER,S.H.NAKAGAWA,P.DE AUTHOR 2 MEYTS,P.G.KATSOYANNIS,M.A.WEISS REVDAT 4 27-OCT-21 1T1Q 1 SEQADV LINK REVDAT 3 28-MAR-12 1T1Q 1 REMARK VERSN REVDAT 2 24-FEB-09 1T1Q 1 VERSN REVDAT 1 10-AUG-04 1T1Q 0 JRNL AUTH K.HUANG,B.XU,S.Q.HU,Y.C.CHU,Q.X.HUA,Y.QU,B.LI,S.WANG, JRNL AUTH 2 R.Y.WANG,S.H.NAKAGAWA,A.M.THEEDE,J.WHITTAKER,P.DE MEYTS, JRNL AUTH 3 P.G.KATSOYANNIS,M.A.WEISS JRNL TITL HOW INSULIN BINDS: THE B-CHAIN ALPHA-HELIX CONTACTS THE L1 JRNL TITL 2 BETA-HELIX OF THE INSULIN RECEPTOR. JRNL REF J.MOL.BIOL. V. 341 529 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15276842 JRNL DOI 10.1016/J.JMB.2004.05.023 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.H.NAKAGAWA,H.S.TAGER,D.F.STEINER REMARK 1 TITL MUTATIONAL ANALYSIS OF INVARIANT VALINE B12 IN INSULIN: REMARK 1 TITL 2 IMPLICATION FOR RECEPTOR BINDING REMARK 1 REF BIOCHEMISTRY V. 39 15826 2000 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 11123908 REMARK 1 DOI 10.1021/BI001802+ REMARK 1 REFERENCE 2 REMARK 1 AUTH C.KRISTEN,T.KJELDSEN,F.C.WIBERG,L.SCHAFFER,M.HACH, REMARK 1 AUTH 2 S.HAVELUND,J.BASS,D.F.STEINER,A.S.ANDERSEN REMARK 1 TITL ALANINE SCANNING MUTAGENESIS OF INSULIN REMARK 1 REF J.BIOL.CHEM. V. 272 12978 1997 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 9148904 REMARK 1 DOI 10.1074/JBC.272.20.12978 REMARK 1 REFERENCE 3 REMARK 1 AUTH Q.Q.WANG,Y.M.FENG,Y.S.ZHANG REMARK 1 TITL STUDIES ON RECEPTOR BINDING SITE OF INSULIN: THE HYDROPHOBIC REMARK 1 TITL 2 B12VALCAN BE SUBSTITUTED BY HYDROPHILIC THR REMARK 1 REF BIOCHEM.MOL.BIOL.INT. V. 39 1245 1996 REMARK 1 REFN ISSN 1039-9712 REMARK 1 PMID 8876979 REMARK 1 REFERENCE 4 REMARK 1 AUTH S.Q.HU,G.T.BURKE,G.P.SCHWARTZ,N.FERDERIGOS,J.B.ROSS, REMARK 1 AUTH 2 P.G.KATSOYANNIS REMARK 1 TITL STERIC REQUIRMENTS AT POSITION B12 FOR HIGH BIOLOGICAL REMARK 1 TITL 2 ACTIVITY IN INSULIN REMARK 1 REF BIOCHEMISTRY V. 32 2631 1993 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 8448120 REMARK 1 REFERENCE 5 REMARK 1 AUTH G.P.SCHWARTZ,P.G.BURKE,P.G.KATSOYANNIS REMARK 1 TITL [12-ASPARAGINE-B] HUMAN INSULIN. AN ANALOGUE WITH REMARK 1 TITL 2 MODIFICATION IN THEHYDROPHOBIC CORE OF INSULIN REMARK 1 REF INT.J.PEPT.PROTEIN RES. V. 17 243 1981 REMARK 1 REFN ISSN 0367-8377 REMARK 1 PMID 7014485 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DGII INSIGHTII 2000, X-PLOR 3.85 REMARK 3 AUTHORS : MOLECULAR SIMULATIONS INC. (DGII), BRUNGER (X REMARK 3 -PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 590 RESTRAINTS: 527 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 39 ARE REMARK 3 DIHEDRAL ANGLE RESTRAINTS, 24 ARE HYDROGEN BOND RESTRAINTS. REMARK 4 REMARK 4 1T1Q COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000022201. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 305 REMARK 210 PH : 7.0; 7.6 REMARK 210 IONIC STRENGTH : NULL; NULL REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1.2 MM ABA-B12-DKP-INSULIN, 90% REMARK 210 H2O, 10% D2O; 1.2 MM ABA-B12-DKP- REMARK 210 INSULIN,100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA; DRX REMARK 210 SPECTROMETER MANUFACTURER : VARIAN; BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : DISTANCE GEOMETRY AND SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED BY USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H ASN A 21 O GLY B 23 1.48 REMARK 500 O GLY B 8 H LEU B 11 1.49 REMARK 500 O GLU B 13 H LEU B 17 1.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 13 -28.43 -38.53 REMARK 500 1 CYS B 19 -78.95 -116.03 REMARK 500 1 LYS B 28 116.73 61.48 REMARK 500 1 PRO B 29 -77.53 -77.42 REMARK 500 2 LEU A 13 -40.06 -28.80 REMARK 500 2 VAL B 2 -112.13 -86.11 REMARK 500 2 CYS B 7 -80.64 -120.35 REMARK 500 2 CYS B 19 -77.94 -116.97 REMARK 500 2 LYS B 28 79.71 170.66 REMARK 500 3 GLN A 5 -87.37 -102.86 REMARK 500 3 THR A 8 30.08 -89.79 REMARK 500 3 SER A 9 -167.62 164.35 REMARK 500 3 VAL B 2 50.88 -97.39 REMARK 500 3 ASN B 3 84.05 -50.21 REMARK 500 3 CYS B 19 -61.10 -94.52 REMARK 500 3 GLU B 21 87.77 -65.40 REMARK 500 3 ARG B 22 -35.39 174.62 REMARK 500 3 LYS B 28 89.37 -163.84 REMARK 500 4 GLN A 5 -102.74 -101.07 REMARK 500 4 SER A 9 -157.82 -120.26 REMARK 500 4 LEU A 13 -56.97 -23.60 REMARK 500 4 ASN B 3 24.40 40.53 REMARK 500 4 CYS B 19 -73.91 -108.45 REMARK 500 5 LEU A 13 -44.92 -27.04 REMARK 500 5 ASN B 3 47.12 39.52 REMARK 500 5 CYS B 19 -58.62 -131.63 REMARK 500 5 PHE B 24 124.08 -171.46 REMARK 500 6 GLN A 5 -75.94 -95.53 REMARK 500 6 SER A 9 -156.50 -146.15 REMARK 500 6 VAL B 2 -88.85 -100.25 REMARK 500 6 ASN B 3 53.40 -111.01 REMARK 500 6 LEU B 6 115.43 -177.36 REMARK 500 6 GLU B 13 -60.93 -91.73 REMARK 500 6 CYS B 19 -73.95 -130.78 REMARK 500 7 VAL A 3 -16.99 -49.91 REMARK 500 7 GLN A 5 -76.63 -99.84 REMARK 500 7 SER A 9 -167.61 -118.89 REMARK 500 7 VAL B 2 -103.50 -60.26 REMARK 500 7 LEU B 6 -163.37 -119.06 REMARK 500 7 CYS B 7 -86.68 -165.90 REMARK 500 7 CYS B 19 -75.75 -128.47 REMARK 500 7 LYS B 28 97.55 -178.27 REMARK 500 7 PRO B 29 -160.79 -78.49 REMARK 500 8 GLN A 5 -65.21 -97.16 REMARK 500 8 CYS A 7 -85.36 -76.60 REMARK 500 8 SER A 9 -167.88 -128.27 REMARK 500 8 LEU A 13 -27.43 -39.23 REMARK 500 8 VAL B 2 53.21 -100.36 REMARK 500 8 ASN B 3 92.16 -53.22 REMARK 500 8 CYS B 7 -98.51 -117.55 REMARK 500 REMARK 500 THIS ENTRY HAS 95 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG B 22 0.31 SIDE CHAIN REMARK 500 2 ARG B 22 0.21 SIDE CHAIN REMARK 500 4 ARG B 22 0.27 SIDE CHAIN REMARK 500 5 ARG B 22 0.31 SIDE CHAIN REMARK 500 6 ARG B 22 0.29 SIDE CHAIN REMARK 500 7 ARG B 22 0.24 SIDE CHAIN REMARK 500 8 ARG B 22 0.21 SIDE CHAIN REMARK 500 9 ARG B 22 0.30 SIDE CHAIN REMARK 500 10 ARG B 22 0.24 SIDE CHAIN REMARK 500 11 ARG B 22 0.31 SIDE CHAIN REMARK 500 12 ARG B 22 0.31 SIDE CHAIN REMARK 500 13 ARG B 22 0.14 SIDE CHAIN REMARK 500 14 ARG B 22 0.17 SIDE CHAIN REMARK 500 15 ARG B 22 0.24 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LNP RELATED DB: PDB REMARK 900 PARENT MOLECULE OF THIS DEPOSITION, CONTAINS THREE SUBSTITUTIONS REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 ALA-B12-DKP-INSULIN REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 THR-B12-DKP-INSULIN DBREF 1T1Q A 1 21 UNP P01308 INS_HUMAN 1 21 DBREF 1T1Q B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 1T1Q ASP B 10 UNP P01308 HIS 34 ENGINEERED MUTATION SEQADV 1T1Q ABA B 12 UNP P01308 VAL 36 ENGINEERED MUTATION SEQADV 1T1Q LYS B 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 1T1Q PRO B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER ASP LEU ABA GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR LYS PRO THR MODRES 1T1Q ABA B 12 ALA ALPHA-AMINOBUTYRIC ACID HET ABA B 12 13 HETNAM ABA ALPHA-AMINOBUTYRIC ACID FORMUL 2 ABA C4 H9 N O2 HELIX 1 1 SER A 12 GLU A 17 1 6 HELIX 2 2 CYS B 7 CYS B 19 1 13 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.01 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 LINK C LEU B 11 N ABA B 12 1555 1555 1.30 LINK C ABA B 12 N GLU B 13 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1